These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 360353)

  • 1. [Treatment of multiple sclerosis by Azathioprine. About 77 cases studied during 10 years (author's transl)].
    Aimard G; Confavreux C; Trouillas P; Devic M
    Rev Neurol (Paris); 1978 Mar; 134(3):215-22. PubMed ID: 360353
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of multiple sclerosis with levamisole and azathioprine. Comparison of the effectiveness, of an 'immunostimulative' and 'immunosuppressive' treatment (author's transl)].
    Patzold U; Haller P; Haas J; Pocklington P; Deicher H
    Nervenarzt; 1978 May; 49(5):285-94. PubMed ID: 673085
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F; Marteau R; de Saxcé H
    Rev Neurol (Paris); 1987; 143(2):98-107. PubMed ID: 3299618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive treatment of multiple sclerosis. 4. Results of treatment with azathioprine and antilymphocyte globulin (author's transl)].
    Frick E; Angstwurm H; Blomer R; Strauss G
    MMW Munch Med Wochenschr; 1977 Sep; 119(35):1111-4. PubMed ID: 408666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of multiple sclerosis with azathioprine (Imuran)].
    Ciesielski T; Burczyk-Popko I; Goralski H; Sypniewski J; Cendrowski W
    Pol Tyg Lek; 1974 Jan; 29(3):101-2. PubMed ID: 4594954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunosuppressive treatment of multiple sclerosis. 3. Results of treatment with azathioprine and antilymphocytic globulin (author's transl)].
    Frick E; Angstwurm H; Strauss G
    MMW Munch Med Wochenschr; 1974 Nov; 116(48):2105-12. PubMed ID: 4216823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Study of 213 cases of multiple sclerosis treated with azathioprine from 1967- to 1982].
    Aimard G; Confavreux C; Ventre JJ; Guillot M; Devic M
    Rev Neurol (Paris); 1983; 139(8-9):509-13. PubMed ID: 6648202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunosuppressive treatment in multiple sclerosis].
    Minderhoud JM; Prange AJ; Luijckx GJ
    Ned Tijdschr Geneeskd; 1987 May; 131(22):966-7. PubMed ID: 3299110
    [No Abstract]   [Full Text] [Related]  

  • 9. Azathioprine in multiple sclerosis: the cons.
    Silberberg DH
    Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term immunosuppression in multiple sclerosis: evaluation of treatments begun before 1972].
    Sabouraud O; Oger J; Darcel F; Madigand M; Merienne M
    Rev Neurol (Paris); 1984; 140(2):125-30. PubMed ID: 6710012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Are there any changes in CSF IgG levels in multiple sclerosis treated for long periods with an immunosuppressive agent (azathioprine)?].
    Oger J; Cloarec L; Chatel M; Sabouraud O
    Nouv Presse Med; 1973 Feb; 2(7):443. PubMed ID: 4631717
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience with azathioprine: the pros.
    Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Nuwer MR
    Neurology; 1988 Jul; 38(7 Suppl 2):20-3. PubMed ID: 3290709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Haematological changes following long-term treatment of multiple sclerosis and myasthenia with azathioprin (author's transl)].
    Haas J; Patzold U
    Nervenarzt; 1982 Feb; 53(2):105-9. PubMed ID: 6801533
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prolonged treatment of multiple sclerosis with average doses of azathioprine. An evaluation of 15 years' experience].
    Lhermitte F; Marteau R; Roullet E; de Saxcé H; Loridan M
    Rev Neurol (Paris); 1984; 140(10):553-8. PubMed ID: 6438761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current studies of the effects of immunosuppressive agents on multiple sclerosis].
    Minderhoud JM
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):99-100. PubMed ID: 2646546
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.
    Lance EM; Kremer M; Abbosh J; Jones VE; Knight S; Medawar PB
    Clin Exp Immunol; 1975 Jul; 21(1):1-12. PubMed ID: 1237376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine and methotrexate in multiple sclerosis.
    Fernández O; Fernández V; De Ramón E
    J Neurol Sci; 2004 Aug; 223(1):29-34. PubMed ID: 15261557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary reports on a therapeutical trial in multiple sclerosis.
    Floris V; Spadaro M; Tilia G
    Riv Neurol; 1987; 57(3):185-8. PubMed ID: 3313667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term therapeutic trials and multiple sclerosis: a wager?].
    Confavreux C
    Rev Neurol (Paris); 1983; 139(6-7):431-7. PubMed ID: 6412341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.